| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical study of the HIV-1 protease inhibitor, 141W94 (VX-478) to evaluate a new soft gelatin capsule formulation and to determine the effects of food upon bioavailability
|
|
|
1996
|
30 |
1 |
p. A42-
1 p.
|
artikel
|
| 2 |
A compound derived from prodocarpic acid inhibits influenza a virus replication in vitro
|
|
|
1996
|
30 |
1 |
p. A27-
1 p.
|
artikel
|
| 3 |
Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC, Cidofovir) against murine and human polyomavirus replication in vitro
|
|
|
1996
|
30 |
1 |
p. A55-
1 p.
|
artikel
|
| 4 |
ADA, a potential anti-HIV drug
|
|
|
1996
|
30 |
1 |
p. A41-
1 p.
|
artikel
|
| 5 |
A dot blot method for detection of HHV-6 antigens and its utilization for evaluating antiviral drugs
|
Yoshida, M.
|
|
1996
|
30 |
1 |
p. A51-
1 p.
|
artikel
|
| 6 |
Allopurinol potentiates the activity of vidarabine against herpes simplex virus in vitro
|
|
|
1996
|
30 |
1 |
p. A47-
1 p.
|
artikel
|
| 7 |
An application of MTT-colorimetric assay for the screening of anti-adenovirus agents
|
|
|
1996
|
30 |
1 |
p. A54-
1 p.
|
artikel
|
| 8 |
A new class of herpesvirus inhibitors differentially affects herpes simplex virus and human cytomegalovirus DNA replication
|
|
|
1996
|
30 |
1 |
p. A43-
1 p.
|
artikel
|
| 9 |
A new method to introduce antiviral substances directly into the brain
|
Ueda, S.
|
|
1996
|
30 |
1 |
p. A56-
1 p.
|
artikel
|
| 10 |
An orally bioavailable sulfated oligosaccharide derivative that inhibits human immunodeficiency virus in vitro and provides sustainned drug level in mammals with low-anticoagulant activity
|
|
|
1996
|
30 |
1 |
p. A32-
1 p.
|
artikel
|
| 11 |
A novel drug delivery system for the controlled release of antivirals in combination therapy
|
|
|
1996
|
30 |
1 |
p. A37-
1 p.
|
artikel
|
| 12 |
A novel mutation (K70E) in HIV-1 reverse transcriptase confers resistance to PMEA in vitro
|
|
|
1996
|
30 |
1 |
p. A32-
1 p.
|
artikel
|
| 13 |
Anti-hantaan virus activity of synthetic coumarrin analogue in vitro
|
|
|
1996
|
30 |
1 |
p. A39-
1 p.
|
artikel
|
| 14 |
Anti-HBV and anti-HIV activities of dioxolane-purine nucleosides
|
|
|
1996
|
30 |
1 |
p. A24-
1 p.
|
artikel
|
| 15 |
Anti-HIV activity of lecithinized superoxide dismutase
|
|
|
1996
|
30 |
1 |
p. A32-
1 p.
|
artikel
|
| 16 |
Anti-HIV agent 1592U89 succinate - progress from synthesis through clinical development
|
|
|
1996
|
30 |
1 |
p. A17-
1 p.
|
artikel
|
| 17 |
Anti-influenza virus activity of plant flavonoid, 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of scutellaria baicalensis and enhancement of its activity by drug delivery system (DDS)
|
|
|
1996
|
30 |
1 |
p. A25-
1 p.
|
artikel
|
| 18 |
Anti-influenza virus activity of pyrimidine derivatives
|
|
|
1996
|
30 |
1 |
p. A51-
1 p.
|
artikel
|
| 19 |
Anti-rotavirus activity of pyrimidine derivatives
|
|
|
1996
|
30 |
1 |
p. A38-
1 p.
|
artikel
|
| 20 |
Antisense oligonucleotide-mediated inhibition of hepatitis C virus gene expression in transformed hepatocytes
|
|
|
1996
|
30 |
1 |
p. A23-
1 p.
|
artikel
|
| 21 |
Antivirał activity of a sulfated polysaccharide extracted from the marine Pseudomonas and marine plant Dinoflagellata against human immunodeficiency viruses and other enveloped viruses
|
Hashimoto, K.
|
|
1996
|
30 |
1 |
p. A31-
1 p.
|
artikel
|
| 22 |
Antiviral activities induced by becombinant BCG vector-based vaccine for HIV-1 in cynomolgus monkeys
|
Honda, M.
|
|
1996
|
30 |
1 |
p. A58-
1 p.
|
artikel
|
| 23 |
Antiviral activity of alkylglycerol foscarnet analogs in HIV-1 infected HT4-6C cells: Structure-activity studies
|
|
|
1996
|
30 |
1 |
p. A20-
1 p.
|
artikel
|
| 24 |
Antiviral activity of the protease inhibitor KNI-272 in vivo in the HIV-infected HuPBMC-SCID mouse model
|
|
|
1996
|
30 |
1 |
p. A18-
1 p.
|
artikel
|
| 25 |
Antiviral and antiinflammatory effects of pulmonary-delivered recombinant murine interferon-γ in a murine Coxsackievirus B3 model
|
|
|
1996
|
30 |
1 |
p. A55-
1 p.
|
artikel
|
| 26 |
Antiviral drug susceptibility of herpes simplex virus type 2 (HSV-2) strains emerging under the selective pressure of various acyclic nucleoside phosphonate analogues in vitro
|
|
|
1996
|
30 |
1 |
p. A47-
1 p.
|
artikel
|
| 27 |
Antiviral effect of the extract of culture medium of lentinus edodes mycelia on the replication of human cytomegalovirus in human cells
|
|
|
1996
|
30 |
1 |
p. A50-
1 p.
|
artikel
|
| 28 |
Antiviral effects of milk proteins: Acylation results in polyanionic compounds with potent activity against HIV type I and II in vitro
|
Swart, P.J.
|
|
1996
|
30 |
1 |
p. A41-
1 p.
|
artikel
|
| 29 |
Antiviral effects of plasma and milk proteins: Lactoferrin shows potent antiviral activity on both HIV and HCMV replication in vitro in the same concentration range
|
Swart, P.J.
|
|
1996
|
30 |
1 |
p. A35-
1 p.
|
artikel
|
| 30 |
Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice
|
|
|
1996
|
30 |
1 |
p. A48-
1 p.
|
artikel
|
| 31 |
Antiviral efficacy of PMPA in macaques chronically infected with SIV
|
Bischofberger, Norbert
|
|
1996
|
30 |
1 |
p. A42-
1 p.
|
artikel
|
| 32 |
Author index
|
|
|
1996
|
30 |
1 |
p. A59-A60
nvt p.
|
artikel
|
| 33 |
Benzimidazoles for the treatment of human cytomegalovirus
|
|
|
1996
|
30 |
1 |
p. A43-
1 p.
|
artikel
|
| 34 |
Biologically active oligodeoxyribonucleotides-VI1 : Structure-activity relationships of anti-HIV-1 hexadeoxyribonucleotides bearing 3′- and 5′-End-modifications
|
|
|
1996
|
30 |
1 |
p. A32-
1 p.
|
artikel
|
| 35 |
Biological measurement of drug sensitivity of HIV-1 in peripheral blood mononuclear cells of a patient by the plaque hybridization assay
|
|
|
1996
|
30 |
1 |
p. A33-
1 p.
|
artikel
|
| 36 |
Calanolides A and B. Synthesis, activities, and structure-activity relationships among congeners
|
Baker, David C.
|
|
1996
|
30 |
1 |
p. A40-
1 p.
|
artikel
|
| 37 |
Cell type-dependent effect of sodium valproate on HIV-1 replication in vitro
|
|
|
1996
|
30 |
1 |
p. A34-
1 p.
|
artikel
|
| 38 |
CGP 61755, a potential combination partner for saquinavir: A synergistic HIV-1 protease inhibitor with high antiviral potency
|
|
|
1996
|
30 |
1 |
p. A33-
1 p.
|
artikel
|
| 39 |
Characterization of a new class of respiratory syncytial virus agents inhibiting the fusion process
|
|
|
1996
|
30 |
1 |
p. A27-
1 p.
|
artikel
|
| 40 |
Clinical evaluation of carbocyclic oxetanocin G eye drops in the treatment of ulcerative herpetic keratitis
|
|
|
1996
|
30 |
1 |
p. A48-
1 p.
|
artikel
|
| 41 |
Combinated antiviral effect of BC30 and MY-13
|
|
|
1996
|
30 |
1 |
p. A54-
1 p.
|
artikel
|
| 42 |
Combination effects of vesnarinone with zidovudine or stavudine (D4T) on HIV replication in peripheral blood mononuclear cells
|
|
|
1996
|
30 |
1 |
p. A33-
1 p.
|
artikel
|
| 43 |
Combinatorial libraries as tools in drug-discovery: Identification of a Tat/TAR inhibitor that suppresses HIV-1 replication
|
|
|
1996
|
30 |
1 |
p. A17-
1 p.
|
artikel
|
| 44 |
Comparison of the in vivo genotoxicity of penciclovir (PCV) acyclovir (ACV), ganciclovir (GCV), and caffeine (CAF)
|
|
|
1996
|
30 |
1 |
p. A45-
1 p.
|
artikel
|
| 45 |
Comparison study of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR on different cell models
|
|
|
1996
|
30 |
1 |
p. A34-
1 p.
|
artikel
|
| 46 |
Conference committees
|
|
|
1996
|
30 |
1 |
p. A5-A6
nvt p.
|
artikel
|
| 47 |
Corneal tissue culture: A novel model for the study of activity of antiviral agents against adenovirus and HSV
|
|
|
1996
|
30 |
1 |
p. A21-
1 p.
|
artikel
|
| 48 |
Corporate sponsors
|
|
|
1996
|
30 |
1 |
p. A7-A9
nvt p.
|
artikel
|
| 49 |
Cyclic HPMPC (cHPMPC) is hydrolyzed to cidofovir (CDV) by an intracellular cCMP phosphodiesterase
|
|
|
1996
|
30 |
1 |
p. A49-
1 p.
|
artikel
|
| 50 |
Detection of unintegrated forms of HIV-1 DNA in cell cultures and in clinical samples
|
|
|
1996
|
30 |
1 |
p. A34-
1 p.
|
artikel
|
| 51 |
Differential sorting of hepatitis B virus (HBV) glycoproteins and DNA caused by unprocessed glycan
|
|
|
1996
|
30 |
1 |
p. A37-
1 p.
|
artikel
|
| 52 |
Directed generation and characterization of clinically important, resistance associated mutants of HIV-1 protease
|
|
|
1996
|
30 |
1 |
p. A31-
1 p.
|
artikel
|
| 53 |
3D modeling of HCV protease and computer screening of its inhibitors
|
Matsumoto, Y.
|
|
1996
|
30 |
1 |
p. A23-
1 p.
|
artikel
|
| 54 |
Dramatic combination therapy with ribavirin and polyoxometalate in the treatment of influenza A virus infected mice
|
|
|
1996
|
30 |
1 |
p. A53-
1 p.
|
artikel
|
| 55 |
Drug discovery assays for hepatitis c virus (HCV) NS3 ATPase/Helicase
|
|
|
1996
|
30 |
1 |
p. A25-
1 p.
|
artikel
|
| 56 |
Editorial Board
|
|
|
1996
|
30 |
1 |
p. ii-
1 p.
|
artikel
|
| 57 |
Effectiveness of ACV for Meniere's disease(MD)
|
Shichinohe, M.
|
|
1996
|
30 |
1 |
p. A56-
1 p.
|
artikel
|
| 58 |
Effectiveness of the combined use of inactivated vaccine (IV) and the inhibitor of proteolysis e-aminocaroic acid (E-ACA) in prevention of experimental influenza
|
|
|
1996
|
30 |
1 |
p. A53-
1 p.
|
artikel
|
| 59 |
Effect of combination therapy with ribavirin and human interferon alfa on subacute sclerosing panencephalitis (SSPE) virus in hamsters
|
|
|
1996
|
30 |
1 |
p. A55-
1 p.
|
artikel
|
| 60 |
Effect of lithium in immunodeficiency: Improved hematopoiesis and increased survival following LP-BM5 murine leukemia virus (MuLV) infection
|
|
|
1996
|
30 |
1 |
p. A58-
1 p.
|
artikel
|
| 61 |
Effects of protease inhibitors on the cleavage of influenza HA glycoprotein mimic by human respiratory tract protease
|
|
|
1996
|
30 |
1 |
p. A52-
1 p.
|
artikel
|
| 62 |
Effects of temporal treatments of nucleoside analogs on replication of epstein-barr virus
|
|
|
1996
|
30 |
1 |
p. A50-
1 p.
|
artikel
|
| 63 |
Efficacy of 6-chloro-2′,3′-dideoxyguanosine in rhesus monkeys infected with simian immunodeficiency virus
|
|
|
1996
|
30 |
1 |
p. A42-
1 p.
|
artikel
|
| 64 |
Efficacy of Glutathione on experimental HSV-1 keratitis
|
|
|
1996
|
30 |
1 |
p. A48-
1 p.
|
artikel
|
| 65 |
Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice
|
Sudo, Kenji
|
|
1996
|
30 |
1 |
p. A54-
1 p.
|
artikel
|
| 66 |
Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography
|
|
|
1996
|
30 |
1 |
p. A36-
1 p.
|
artikel
|
| 67 |
Establishment of assay system for screening of human cytomegarovirus UL80-proteinase inhibitor
|
Watanabe, Shinya
|
|
1996
|
30 |
1 |
p. A49-
1 p.
|
artikel
|
| 68 |
Evaluation of long-term treatment with glycyrrhizin and of combination therapy with glycyrrhizin and AZT or DDI on HIV-1 carriers
|
Ikegami, N.
|
|
1996
|
30 |
1 |
p. A33-
1 p.
|
artikel
|
| 69 |
FIAU is phosphorylated and inhibits DNA synthesis in isolated rat mitochondria
|
|
|
1996
|
30 |
1 |
p. A38-
1 p.
|
artikel
|
| 70 |
2′Fluoro 5 methylβL-arabinofuranosyluracil, a novel L-nucleoside analog, inhibits duck hepatitis b virus replication in primary hepatocytes and in vivo
|
|
|
1996
|
30 |
1 |
p. A24-
1 p.
|
artikel
|
| 71 |
Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate
|
Weg, Müller
|
|
1996
|
30 |
1 |
p. A38-
1 p.
|
artikel
|
| 72 |
Future conferences
|
|
|
1996
|
30 |
1 |
p. A61-
1 p.
|
artikel
|
| 73 |
Ganciclovir resistant CMV: Implications of UL97 and polymerase mutations in cross resistance to cidofovir
|
|
|
1996
|
30 |
1 |
p. A44-
1 p.
|
artikel
|
| 74 |
Genetic alternation of the hepatitis C hypervariable region in children with chronic hepatitis C
|
|
|
1996
|
30 |
1 |
p. A37-
1 p.
|
artikel
|
| 75 |
2-glycineamide-5-chlorophenyl(2-pyril) ketone is a novel tat inhibitor which have no benzodiazepine formula
|
|
|
1996
|
30 |
1 |
p. A18-
1 p.
|
artikel
|
| 76 |
HIV-1 preintegration complex is transported to the nuclei along the cellular membranes
|
|
|
1996
|
30 |
1 |
p. A34-
1 p.
|
artikel
|
| 77 |
Inactivation of influenza and other viruses by pinorin
|
|
|
1996
|
30 |
1 |
p. A52-
1 p.
|
artikel
|
| 78 |
Influence of hepatitis B virus genotype on interferon response in HBe antigen negative chronic hepatitis B
|
|
|
1996
|
30 |
1 |
p. A24-
1 p.
|
artikel
|
| 79 |
Influenza B/Lee/40 neuraminidase: X-ray structure of the enzyme complexed with 4-guanidino-Neu5Ac2en
|
|
|
1996
|
30 |
1 |
p. A26-
1 p.
|
artikel
|
| 80 |
Inhibition of influenza a virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin
|
|
|
1996
|
30 |
1 |
p. A27-
1 p.
|
artikel
|
| 81 |
Inhibition of influenza viral polymerases by mini-RNA genomes guangxiang luo
|
|
|
1996
|
30 |
1 |
p. A52-
1 p.
|
artikel
|
| 82 |
Inhibition of influenza virus RNA polymerase and nucleoprotein of gene expression by antisense oligonucleotides
|
Hatta, T.
|
|
1996
|
30 |
1 |
p. A25-
1 p.
|
artikel
|
| 83 |
Inhibitors of influenza virus neuraminidase: Their interaction with enzymes from sensitive and resistant viruses
|
|
|
1996
|
30 |
1 |
p. A27-
1 p.
|
artikel
|
| 84 |
Inhibitory effect of cytokines in breast milk for the reactivation of human cytomegalovirus
|
|
|
1996
|
30 |
1 |
p. A50-
1 p.
|
artikel
|
| 85 |
Inhibitory effect of 2-phosphonomethoxyalkyl derivatives of N6-substituted 6-aminopurines on epstein barr virus (EBV)
|
|
|
1996
|
30 |
1 |
p. A51-
1 p.
|
artikel
|
| 86 |
Introduction to sponsors
|
|
|
1996
|
30 |
1 |
p. A7-
1 p.
|
artikel
|
| 87 |
In vitro and in vivo influenza-inhibitory effects of a series of polyoxometalates
|
|
|
1996
|
30 |
1 |
p. A28-
1 p.
|
artikel
|
| 88 |
In vivo anti-influenza virus activity of kampo (japanese herbal) medicine “sho-seiryu-to (xiao-qing-long-tang)”
|
|
|
1996
|
30 |
1 |
p. A53-
1 p.
|
artikel
|
| 89 |
Kinetic and mechanistic studies of the interactions of ganciclovir triphosphate with human DNA polymerases α, β, γ and human cytomegalovirus DNA polymerase
|
|
|
1996
|
30 |
1 |
p. A50-
1 p.
|
artikel
|
| 90 |
Linking AZT to ceramide increases drug uptake, retention and antiviral action while decreasing bone marrow toxicity
|
|
|
1996
|
30 |
1 |
p. A19-
1 p.
|
artikel
|
| 91 |
Liposome encapsulated nucleoside 5′-phosphate prodrugs: a strategy to introduce 5′-nucleotides into cells
|
|
|
1996
|
30 |
1 |
p. A41-
1 p.
|
artikel
|
| 92 |
Mechanism of anti-HIV action of masked alaninyl 2′,3′-dideoxy-2′,3′-didehydrothymidine 5′-monophosphate derivatives
|
|
|
1996
|
30 |
1 |
p. A18-
1 p.
|
artikel
|
| 93 |
Metabolic fate and mode of antiviral action of sorivudine in HSV-1 infected cells
|
|
|
1996
|
30 |
1 |
p. A48-
1 p.
|
artikel
|
| 94 |
Modulation of antiherpes activity by deoxyguanosine
|
|
|
1996
|
30 |
1 |
p. A47-
1 p.
|
artikel
|
| 95 |
Natural interferon- α treatment in chronic hepatitis B(HB) with pre-core stop codon mutation
|
Ito, Y.
|
|
1996
|
30 |
1 |
p. A36-
1 p.
|
artikel
|
| 96 |
Novel 2-amino-9-(1,3-dihydroxy-2-propoxymethyl)-6-fluoropurine mono- and diesters as potential prodrugs of ganciclovir
|
|
|
1996
|
30 |
1 |
p. A44-
1 p.
|
artikel
|
| 97 |
Novel anti-respiratory syncytial (RS) viral compounds; benzoditiin derivatives
|
Watanabe, Wataru
|
|
1996
|
30 |
1 |
p. A53-
1 p.
|
artikel
|
| 98 |
2-Nucleosyl-4H-1,3,2-benzodioxophosphorine-2-oxides. A new concept for lipophilic prodrugs of biologically active nucleoside monophosphates
|
|
|
1996
|
30 |
1 |
p. A29-
1 p.
|
artikel
|
| 99 |
Pentafuside (T20), a novel inhibitor of HIV-1 fusion: Pharmacokinetics and in vivo efficacy
|
|
|
1996
|
30 |
1 |
p. A18-
1 p.
|
artikel
|
| 100 |
Pharmacokinetics of 141W94 after multiple dosing in patients with HIV infection: A preliminary report
|
|
|
1996
|
30 |
1 |
p. A42-
1 p.
|
artikel
|
| 101 |
Phase I clinical trial with a novel protease inhibitor for HIV, KVX-478, in healthy male volunteers
|
|
|
1996
|
30 |
1 |
p. A35-
1 p.
|
artikel
|
| 102 |
Photoaffinity labeling of HIV reverse transcriptase: Synthesis and utilization of 2′,3′-dideoxy uridylate analogs bearing aryl(trifluoromethyl)diazirine moiety
|
Yamaguchi, T.
|
|
1996
|
30 |
1 |
p. A31-
1 p.
|
artikel
|
| 103 |
Point mutation in the DNA polymerase gene of a clinical cytomegalovirus isolate which was cross-resistant to GCV and (s)-HPMPC
|
|
|
1996
|
30 |
1 |
p. A49-
1 p.
|
artikel
|
| 104 |
Polysaccharide induced-apoptotic cell death of variuos human lymphoid cells integrated with virus genome
|
|
|
1996
|
30 |
1 |
p. A38-
1 p.
|
artikel
|
| 105 |
Potent inhibition of HIV-1 replication in vivo by a novel inhibitor of HIV-1 fusion
|
|
|
1996
|
30 |
1 |
p. A31-
1 p.
|
artikel
|
| 106 |
Prolonged presence of viral DNA in serum and CSF in neonatal herpes simplex virus infections
|
Morishima, T.
|
|
1996
|
30 |
1 |
p. A22-
1 p.
|
artikel
|
| 107 |
Prophylactic efficacy of traditional herbal medicines against recurrent herpes simplex virus infection in mice and guinea pigs
|
|
|
1996
|
30 |
1 |
p. A22-
1 p.
|
artikel
|
| 108 |
Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a modified oligonuleotide, RKS-1443
|
Agatsuma, T.
|
|
1996
|
30 |
1 |
p. A35-
1 p.
|
artikel
|
| 109 |
Purification, utilization of exogenous template and application of reverse transcriptase of DHBV replicative complexes
|
|
|
1996
|
30 |
1 |
p. A36-
1 p.
|
artikel
|
| 110 |
Randomized phase II studies of VIRACEPTTM, an HIV protease inhibitor, given as monotherapy and in combination with stavudine (d4T)
|
|
|
1996
|
30 |
1 |
p. A19-
1 p.
|
artikel
|
| 111 |
Recurrent and prolonged herpes simplex encephalitis
|
Shoji, H.
|
|
1996
|
30 |
1 |
p. A49-
1 p.
|
artikel
|
| 112 |
Resistance of influenza a and b viruses to 4-Guanidino-Neu5Ac2en
|
|
|
1996
|
30 |
1 |
p. A26-
1 p.
|
artikel
|
| 113 |
Rheum palmatum therapy for herpes simplex virus infection in mice
|
|
|
1996
|
30 |
1 |
p. A45-
1 p.
|
artikel
|
| 114 |
S-Adenosylhomocysteine hydrolase inhibitors as potent anti-RNA viral agents
|
|
|
1996
|
30 |
1 |
p. A54-
1 p.
|
artikel
|
| 115 |
Scientific program
|
|
|
1996
|
30 |
1 |
p. A13-A16
nvt p.
|
artikel
|
| 116 |
Selectability of varicella-zoster virus resistant to acyclovir and penciclovir
|
|
|
1996
|
30 |
1 |
p. A21-
1 p.
|
artikel
|
| 117 |
Selective activity of cholic acid and related compounds against herpes simplex virus type 2
|
|
|
1996
|
30 |
1 |
p. A46-
1 p.
|
artikel
|
| 118 |
Serial chages in titers of antibody to hepatitis B antigen after immunization of infants born to mother with hepatitis B E antigen
|
|
|
1996
|
30 |
1 |
p. A36-
1 p.
|
artikel
|
| 119 |
Serum HCV RNA levels using by the branched DNA amplification assay in children with chronic hepatitis C
|
|
|
1996
|
30 |
1 |
p. A24-
1 p.
|
artikel
|
| 120 |
Significance of different tests for prognosis of adverse reactions of anthnfluenza drugs
|
|
|
1996
|
30 |
1 |
p. A52-
1 p.
|
artikel
|
| 121 |
Small-sized HIV protease inhibitors containing allophenyinorstatine exhibit antiviral activities
|
Kiso, Y.
|
|
1996
|
30 |
1 |
p. A57-
1 p.
|
artikel
|
| 122 |
Social functions
|
|
|
1996
|
30 |
1 |
p. A11-
1 p.
|
artikel
|
| 123 |
Structure - activity relationship of non-nucleoside RT inhibitor, thiadizaole derivatives
|
Nagano, H.
|
|
1996
|
30 |
1 |
p. A30-
1 p.
|
artikel
|
| 124 |
Structure-activity relationship studies of nucleoside analogs with anti-HIV activity
|
Tsai, C.C.
|
|
1996
|
30 |
1 |
p. A29-
1 p.
|
artikel
|
| 125 |
Study of the mechanism of action of 3(2H)-isoflavene on poliovirus type 2 infection
|
|
|
1996
|
30 |
1 |
p. A55-
1 p.
|
artikel
|
| 126 |
Substance(s) produced by CD8∗ T cells from HIV-1-infected individuals can inhibit replication of HIV-1 and HIV-2 via suppression of transcription
|
Tsuchie, H.
|
|
1996
|
30 |
1 |
p. A40-
1 p.
|
artikel
|
| 127 |
Synthesis, activity against human immunodeficiency virus and cytotoxicity in cell cultures of 5′-carboxyphosphonyl derivatives of dideoxynucleosides
|
|
|
1996
|
30 |
1 |
p. A30-
1 p.
|
artikel
|
| 128 |
Synthesis. Activity against human immunodeficiency virus and cytotoxicity of derivatives of 5-hydroxymethyl-2′-deoxyuridine
|
|
|
1996
|
30 |
1 |
p. A30-
1 p.
|
artikel
|
| 129 |
Synthesis and properties of fluorescent analogues of acyclovir
|
|
|
1996
|
30 |
1 |
p. A47-
1 p.
|
artikel
|
| 130 |
Synthesis and relationship between conformation and antiherpes activity of N4-substituted analogs of 5-methoxymethyl-2′-deoxycytidine (MMdCyd)
|
|
|
1996
|
30 |
1 |
p. A20-
1 p.
|
artikel
|
| 131 |
Synthesis, biological and physical evaluation of some novel glycolipid analogues
|
|
|
1996
|
30 |
1 |
p. A35-
1 p.
|
artikel
|
| 132 |
Synthesis, molecular conformation and antiherpes activity of N4-substituted analogs of (E)-5-(2-bromovinyl)-2′-deoxycytidine (BrVdCyd)
|
|
|
1996
|
30 |
1 |
p. A46-
1 p.
|
artikel
|
| 133 |
Synthetic peptides from conserved regions of HIV-1, HIV-2, and SIV fusion proteins are potent antivirals (inhibitors of viral fusion)
|
|
|
1996
|
30 |
1 |
p. A57-
1 p.
|
artikel
|
| 134 |
T-cell costimulation by derivatives of benzoic acid through an antioxidant-sensitive mechanism
|
|
|
1996
|
30 |
1 |
p. A19-
1 p.
|
artikel
|
| 135 |
The design, chemistry, and antiviral activity of a novel group of anti-herpesvirus prodrugs
|
|
|
1996
|
30 |
1 |
p. A44-
1 p.
|
artikel
|
| 136 |
The differential effects of famciclovir and valaciclovir on the establishment of latent infections in mice
|
|
|
1996
|
30 |
1 |
p. A21-
1 p.
|
artikel
|
| 137 |
The effect of treatment with interferon combined ribavirin on chronic hepatitis C virus
|
Wu, Zhangqi
|
|
1996
|
30 |
1 |
p. A37-
1 p.
|
artikel
|
| 138 |
The effects of combining T-cell immunosuppression with antiviral chemotherapy studied in a murine model for cutaneous HSV
|
|
|
1996
|
30 |
1 |
p. A44-
1 p.
|
artikel
|
| 139 |
The same point mutation within region II of the herpes simplex virus type 1 (HSV-1) DNA polymerase gene confers resistance to foscarnet (PFA) and the phosphonylmethoxyethyl (PME) derivatives of adenine (PMEA) and 2,6-diaminopurine (PMEDAP)
|
|
|
1996
|
30 |
1 |
p. A21-
1 p.
|
artikel
|
| 140 |
The thiocarboxanilides UC-781 and UC-82 are potent HIV-1-specific reverse transcriptase inhibitors that inhibit a broad spectrum of drug-resistant HIV-1 strains
|
|
|
1996
|
30 |
1 |
p. A30-
1 p.
|
artikel
|
| 141 |
Thiadiazole derivatives were highly potent inhibitors of HIV-1
|
|
|
1996
|
30 |
1 |
p. A41-
1 p.
|
artikel
|
| 142 |
Treatment of atypical hemorrhagic fever with renal syndrome (Korean hemorrhagic fever in Korea) with ribavirin: Report of 10 cases
|
|
|
1996
|
30 |
1 |
p. A28-
1 p.
|
artikel
|
| 143 |
Treatment of progressive multifocal leukoencephalopathy (PML) with cidofovir in an AIDS patient
|
|
|
1996
|
30 |
1 |
p. A51-
1 p.
|
artikel
|
| 144 |
Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (cidofovir)
|
|
|
1996
|
30 |
1 |
p. A25-
1 p.
|
artikel
|
Tijdschrift beschrijving